Hypo Awareness Week 2026 has been funded by Roche, Ascensia and Sanofi which has had no input into the campaign's arrangements or content. We anticipate that the campaign will receive further sponsorship from pharmaceutical companies and medical technology companies. Once confirmed it will be added to the relevant pages of the Hypo Awareness Week website and Hypo Awareness Week promotional materials, where appropriate.

Ambassador

Consultant in diabetes and endocrinology, Honorary Professor of Medicine

Prof Ketan Dhatariya

“Hypo awareness week is taking on extra significance this year. With the unavailability of GLP-1 receptor analogues and a greater reliance on insulin and sulfonylurea use, the risk of having a low blood glucose has increased. It’s up to all of us looking after people with diabetes on these agents to make sure they are educated about the risks of hypoglycaemia and what they can do to prevent them and treat them when they occur.”